Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
+44 (0) 203 086 8600 Call us on

Japan Interventional Cardiology Devices: Coronary Stents to Drive Growth

2210.18

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£2,210.18

Change Currency

GBP EURO USD

Market

Healthcare and Medical

Report Type

Market Research

Country

Japan

Published

28 October 2009

Number of Pages

35

Report Delivery

Email

Delivery Lead Time

-

Publisher

GlobalData

The Japan interventional cardiology devices market was valued at around $972 million in 2008 and is forecast to reach $1.4 billion by 2015

Japan Interventional Cardiology Devices Market: Coronary Stents to Drive Growth report is an essential source of data and analysis on the Japan interventional cardiology market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on five market categories, namely, cardiac catheter, coronary guidewire, coronary stent, PTCA balloon and arteriotomy closure devices. The report identifies the key trends shaping and driving the dynamism in the Japanese interventional cardiology market. It also provides insight into the prevalent competitive landscape and on the emerging players who are expected to bring significant shift in the market standing of the existing leaders. In addition, the report analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the Japanese interventional cardiology market.

The Japan interventional cardiology devices market was valued at around $972 million in 2008. The market is forecast to reach $1.4 billion by 2015 with a Compound Annual Growth Rate (CAGR) of 6%. The market is expected to be driven by increasing incidence of coronary disease, increasing preference for minimally invasive procedures, and product innovation enabling physicians to perform Percutaneous Coronary Intervention (PCI) for complex cases.

Scope

The report analyses market opportunities and challenges for the interventional cardiology devices companies in Japan. Its scope includes
- Market size data and information on five interventional cardiology market categories, namely, cardiac catheter, coronary guidewire, coronary stent, PTCA balloon and arteriotomy closure devices
- Annualized market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008
- Analysis and review of the key events and milestones that will impact the future of the Japan interventional cardiology market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the Japan interventional cardiology market
- In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future
- The report covers information on the leading market players such as Medtronic, Inc., Terumo Corporation, Cordis Corporation, Boston Scientific Corporation, and Abbott Laboratories. It also provides insights into the competitive landscape and the leading pipeline products and technologies
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop business strategies by understanding the trends shaping and driving the Japan interventional cardiology Market
- Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the Japan interventional cardiology market in future
- Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- What’s the next big thing in the Japan interventional cardiology technology landscape? – Identify, understand and capitalize

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£2,210.18

Change Currency

GBP EURO USD

Change Currency

GBP
USD

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

AVAMAE Website design and development by
Accessibility
Close

Contrast settings

Text size settings